125459 [ 2024-2026 ]

: Determining where the therapeutic gene goes in the body and how long it persists in both target and non-target cells.

The guideline, officially titled , provides a framework for non-clinical studies required before a gene therapy can be used in human clinical trials. Guide to EMA Guideline 125459

Guideline on the Non-Clinical Studies Required before First ... - EMA 125459

: Defining scientific principles for non-clinical studies specifically for gene therapies, which differ significantly from conventional pharmaceuticals. Key Safety Requirements :

For more detailed technical specifications, you can access the full Guideline on Non-Clinical Studies for GTMPs via the official . : Determining where the therapeutic gene goes in

: Evaluating whether the viral vector or therapeutic gene could unintentionally be passed on to future generations.

: Characterizing potential immune responses to the viral vector or the new protein produced by the therapy. - EMA : Defining scientific principles for non-clinical

The number most commonly refers to a specific scientific guideline established by the European Medicines Agency (EMA) regarding the development of Gene Therapy Medicinal Products (GTMPs) .